














httpThree-dimensional fusion computed tomography
decreases radiation exposure, procedure time, and
contrast use during fenestrated endovascular aortic
repair
Michael M. McNally, MD, Salvatore T. Scali, MD, Robert J. Feezor, MD, Daniel Neal, MS,
Thomas S. Huber, MD, PhD, and Adam W. Beck, MD, Gainesville, Fla
Objective: Endovascular surgery has revolutionized the treatment of aortic aneurysms; however, these improvements have
come at the cost of increased radiation and contrast exposure, particularly for more complex procedures. Three-
dimensional (3D) fusion computed tomography (CT) imaging is a new technology that may facilitate these repairs.
The purpose of this analysis was to determine the effect of using intraoperative 3D fusion CT on the performance of
fenestrated endovascular aortic repair (FEVAR).
Methods: Our institutional database was reviewed to identify patients undergoing branched or FEVAR. Patients treated
using 3D fusion CT were compared with patients treated in the immediate 12-month period before implementation of
this technology when procedures were performed in a standard hybrid operating room without CT fusion capabilities.
Primary end points included patient radiation exposure (cumulated air kerma: mGy), ﬂuoroscopy time (minutes),
contrast usage (mL), and procedure time (minutes). Patients were grouped by the number of aortic graft fenestrations
revascularized with a stent graft, and operative outcomes were compared.
Results: A total of 72 patients (41 before vs 31 after 3D fusion CT implementation) underwent FEVAR from
September 2012 through March 2014. For two-vessel fenestrated endografts, there was a signiﬁcant decrease in
radiation exposure (3400 6 1900 vs 1380 6 520 mGy; P [ .001), ﬂuoroscopy time (63 6 29 vs 41 6 11 minutes;
P [ .02), and contrast usage (69 6 16 vs 26 6 8 mL; P [ .0002) with intraoperative 3D fusion CT. Similarly, for
combined three-vessel and four-vessel FEVAR, signiﬁcantly decreased radiation exposure (5400 6 2225 vs 2700 6
1400 mGy; P < .0001), ﬂuoroscopy time (89 6 36 vs 64 6 21 minutes; P [ .02), contrast usage (90 6 25 vs 39 6
17 mL; P < .0001), and procedure time (330 6 100 vs 230 6 50 minutes; P [ .002) was noted. Estimated blood
loss was signiﬁcantly less (P < .0001), and length of stay had a trend (P [ .07) toward being lower for all patients in
the 3D fusion CT group.
Conclusions: These results demonstrate that use of intraoperative 3D fusion CT imaging during FEVAR can signiﬁcantly
decrease radiation exposure, procedure time, and contrast usage, which may also decrease the overall physiologic impact of
the repair. (J Vasc Surg 2015;61:309-16.)Fenestrated endovascular aortic repair (FEVAR) is
becoming increasingly common and is now commercially
available in the United States with recent Food and Drug
Administration approval of a customized fenestrated
device. With this technological advancement, there is an
expected decrease in the physiologic insult to the patient
compared with open repair1-3; however, this comes with
increased radiation and contrast exposure risk during thethe Division of Vascular Surgery and Endovascular Therapy,
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://dx.doi.org/10.1016/j.jvs.2014.07.097procedures.4 Fluoroscopy is an important radiation source
in contemporary practice, and an increasing focus on the
effects of cumulative radiation exposure to patients and
providers is present in the literature.4-14 Notably, a recent
report demonstrated that FEVAR is one of the most
radiation-intensive procedures that vascular specialists
perform.4
The FEVAR radiation dose is related not only to
the ﬂuoroscopy time but also to the density of the
abdomen and pelvis and the frequent obliquity that is
necessary to visualize target vessels adequately.13 In addi-
tion, these procedures often require large amounts of
iodinated contrast, which may be partly responsible for
the known decrement in renal function that can occur after
FEVAR.15,16 Importantly, advanced imaging techniques
have been shown to decrease operative times and radiation
exposure as well as mitigate the need for contrast usage
during routine EVAR.17,18
Our institution has recently upgraded to a ﬁxed-
imaging unit capable of three-dimensional (3D) fusion
computed tomography (CT), and we sought to evaluate
how this technology has affected the conduct of FEVAR309
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regard to radiation exposure and contrast usage.
METHODS
The University of Florida Institutional Review Board
(FWA00005790) approved this study protocol
(#201300781). A waiver of informed consent was granted
because all collected data pre-existed in medical records
and no study-related interventions or patient contact
occurred. Therefore, the rights and welfare of these
patients was not adversely affected.
Patient selection. A review of our institutional endo-
vascular aortic database was performed for patients who
underwent FEVAR before and after inauguration of a
hybrid operating room capable of 3D fusion CT imaging.
To mitigate the effect of the learning curve over time,
patients treated using 3D fusion CT imaging were
compared with patients treated in the immediate 12 months
before the availability of the new hybrid unit. Speciﬁcally,
the dates of collection included patients receiving FEVAR
in the 3D fusion CT-capable room beginning in
September 2013 vs those treated in the 365 days before.
A single surgeon (A.W.B.) at our institution began
offering FEVAR in January 2010. We intentionally
excluded the initial 68 cases, of which 48 (69%) were
three-vessel or four-vessel fenestration procedures, span-
ning a 2.5-year period, to minimize the effect of the
operative team learning curve on the results of this study.
In addition, no signiﬁcant operative team personnel or
device implantation technique changes occurred during
the study interval.
The method of target visceral vessel catheterization
has been described previously and did not change signif-
icantly during the study period.19 Patients were grouped
by the number of fenestrations or branches revascularized
(ie, excluding fenestrations or scallops that were not sup-
ported with a stent). Patients undergoing a two-vessel
FEVAR were compared separately from three-vessel and
four-vessel FEVAR patients, and three-vessel and four-
vessel patients were grouped to increase numbers for
comparison. Demographics, comorbidities, intraoperative
characteristics (including adjuncts as deﬁned by the
Society for Vascular Surgery standards20,21), and postop-
erative outcomes were abstracted from our prospective
database or the electronic medical record, or both, as
needed. Comorbidities were deﬁned according to report-
ing guidelines.1
Clinical practice. All patients were recovered in a
dedicated cardiovascular intensive care unit. Patients were
mobilized and given a normal diet on postoperative day
1 if there were no clinical concerns, such as neurologic,
cardiopulmonary, gastrointestinal, hematologic, or renal
system derangements. Thereafter, patients were transferred
to the ﬂoor (unless on the spinal drain protocol), and all
indwelling lines and catheters were removed if clinical
recovery continued to be uneventful. Once patients toler-
ated a regular diet and received evaluation by physical ther-
apy, they were discharged from the hospital. A restrictivetransfusion protocol exists at our institution, and patients
generally receive a transfusion only for a hemoglobin
of <7 g/dL unless there is evidence of hypovolemic
anemia or cardiac ischemia. The need for spinal drainage
was determined by the operating surgeon. Spinal drain pro-
tocols did not change during the study interval and have
been previously published.22
Equipment and procedural details. Patients under-
going FEVAR before the 3D-capable operating room
(no-CT group) availability were treated in a hybrid oper-
ating room using a ﬁxed imaging Inﬁnix VC-i (Toshiba
Medical Systems, Tokyo, Japan) ceiling-mounted, single-
plane system. Fluoroscopy was generally performed at a
low dose of 7.5 frames per second (fps), and digital
subtraction angiography (DSA) was performed at 3 fps,
unless an increased frame rate was necessary for
improved imaging, in which case 6 fps was used. This
system was routinely used in conjunction with intravas-
cular ultrasound (IVUS) imaging using a Volcano cath-
eter (Volcano Corp, San Diego, Calif). Before device
delivery, IVUS imaging was used to determine branch
vessel locations.
After device delivery, a ﬂush catheter was used to
perform DSA in the anterior-posterior and lateral projec-
tions to mark the branch vessel locations. Next, the device
was deployed while the radiopaque fenestration/branch
markers were triangulated against the DSA roadmap imag-
ing. DSA imaging was performed intermittently to facilitate
vessel catheterization and conﬁrm successful access to the
respective target vessels. DSA runs were also routinely
used to perform individual completion runs for the branch
vessels and a completion aortogram. Contrast was mini-
mized by diluting it to one-third strength (Visipaque
320; GE Healthcare, Hertfordshire, United Kingdom)
for hand-injection imaging and to one-half strength for
completion imaging.
Use of the 3D fusion CT-capable hybrid operating
room began in September 2013, which uses an Artis zee
system (Siemens Medical Solutions USA, Inc, Malvern,
Pa; http://usa.healthcare.siemens.com/angio/artis-zee/
artis-zee). Of note, the radiology technicians for our dedi-
cated vascular operating team underwent advanced imag-
ing training through Siemens before our ﬁrst procedure,
which allowed a rather seamless introduction of this tech-
nology into our practice. This unit was also used at a low
dose of 7.5 fps, and DSA was performed at 4 fps.
Before the procedure, the operating surgeon used the
Leonardo workstation (Siemens AG, Forchheim,
Germany) to process the preoperative CT arteriogram
(CTA) by placing digital marks around the oriﬁce of each
branch vessel on the CTA (Fig 1). These marks were saved,
and an intraoperative noncontrast abdominal CT was then
performed before sterile preparation and draping, a process
that takes no more than 2 or 3 minutes, which adds little to
the overall operating room time.
The Artis zee system acquires (Dyna CT) images by
rotating around the patient 200 and obtaining an array
of equally spaced 2D x-ray projection images. For
Fig 1. This image demonstrates the method of overlay mark production and use. A, Marks are placed around the
origins of the superior mesenteric artery (white arrow) and renal arteries (red arrows). B, The intraoperative overlay of
these marks is shown on live ﬂuoroscopy, and the radiopaque markers on the graft can be seen to closely approximate
these overlay marks during deployment. C and D, Images are shown for the same patient in a lateral projection. Note
that a perfectly orthogonal image of the vessel origin can be obtained by aligning the origin marker such that it appears
as a line on the overlay, and this can be aligned before ﬂuoroscopy is initiated, minimizing radiation during adjustment
of the C-arm.
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CTA, the system initially acquired a noncontrasted CT
centered at the visceral segment of the aorta (133 frames
over 5 seconds). The images were sent to the Leonardo
workstation to create the native mask (bony anatomy and
vascular structures) Dyna CT. Dyna CT image data sets
were then reconstructed as a 3D image on the Syngo X
workplace (Siemens). Next, this intraoperative noncon-
trasted CT image was fused to the preoperative CTA using
bony landmarks.
After sterile preparation, draping, and obtaining arterial
access, stiff Lunderquist wires (Cook Medical, Blooming-
ton, Ind) were placed, and IVUS imaging was used to
conﬁrm the preoperatively placed marks, which are seen
as an overlay image on live ﬂuoroscopy (Fig 1). Next, the
vessel origin overlay image was adjusted to correspond to
the IVUS image with the stiff wires in place before device
delivery. The device was then inserted and deployed using
the radiopaque graft markers and the overlay marks dis-
played on live ﬂuoroscopy. Notably, contrast was not
routinely given or required until after each branch vessel
was revascularized using a stent graft.
The 3D overlay image was used selectively to conﬁrm
the wire path as the target vessel of interest, decreasing
the need for DSA during fenestration/branch catheteriza-
tion. DSA was typically reserved for a completion aorto-
gram or during difﬁcult vessel catheterizations. In
patients requiring iliac limbs, IVUS imaging was used to
determine the hypogastric location, and contrast injections
were typically not used for iliac limb deployment. Similar to
FEVAR performed in the other hybrid operating room,
contrast was diluted to one-third strength for all hand-
injection imaging and to one-half strength for completion
DSA. Notably, the power injector was not routinely used
until the completion aortogram, and to prevent settlingof contrast, the one-half strength mixed contrast was not
loaded until the time of the aortogram.
Radiation dose calculation. Radiation exposure is
reported as the cumulated air kerma (CAK), recorded as
mGy, along with total ﬂuoroscopy time (minutes), both
of which are routinely collected in our hybrid operating
rooms for each procedure. Kerma is an acronym for “kinetic
energy released per unit mass,” and provides an
international standard for estimating radiation dose.
Notably, our Toshiba Inﬁnix VC-i system and the
Siemens Artis zee system have similar methods of CAK
determination. This method is guided by Food and Drug
Administration standards, with the reference location for
determination of CAK at 15 cm from the isocenter toward
the x-ray source along the beam axis.
End points and statistics. Primary end points
included radiation dose (CAK), ﬂuoroscopy time, contrast
use, and procedure time (deﬁned as time from skin inci-
sion/puncture to bandage application). Secondary end
points analyzed included total estimated blood loss, length
of stay, complications, and 30-day mortality. Complica-
tions were deﬁned and tabulated based on reporting stan-
dards for endovascular aneurysm repair.21 Estimated
glomerular ﬁltration rate (eGFR) was calculated using the
Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) formula.23
Differences in renal function were calculated using the
nonparametric Kruskal-Wallis and exact Wilcoxon scores
tests. Continuous variables were analyzed using the
Student t-test or Wilcoxon Mann-Whitney test, and cate-
goric variables were compared with a c2 or Fisher exact
test, when indicated. All analysis was completed using R
2.15.0 software (The R Foundation for Statistical
Computing, Vienna, Austria). A P value of <.05 was
considered signiﬁcant.
Table I. Demographics and comorbidities for all patients
Featurea No CT (n ¼ 41) 3D CT (n ¼ 31) P valueb
Age, years 71 6 7 72 6 11 .6
Male sex 32 (78) 21 (67) .5
Body mass index, kg/m2 30 6 6 26 6 4 .01
Comorbidity
Hypertension 39 (95) 25 (81) .06
Dyslipidemia 23 (56) 16 (51) .8
Chronic pulmonary disease 20 (48) 11 (35) .3
Smoking 18 (43) 16 (51) .6
Coronary artery disease 18 (44) 12 (39) .8
Diabetes mellitus 12 (29) 8 (25) .8
Cerebrovascular disease 10 (14) 6 (15) 1
Chronic renal insufﬁciencyc 8 (19) 7 (22) .8
Congestive heart failure 6 (14) 3 (9) .7
Arrhythmia 5 (12) 3 (9) 1
End-stage renal disease 0 2 (7) .2
3D CT, Three-dimensional fusion computed tomography; No CT, no intraoperative computed tomography.
aContinuous data are expressed as mean 6 standard deviation and categoric data as number (%).
bP values were determined with t-tests, c2, or Fisher exact test, when indicated.
cChronic renal insufﬁciency deﬁned as estimated glomerular ﬁltration rate < 50 mL/min/1.73 m2 and/or Cr > 1.6.
Table II. Patient demographics and comorbidities by
number of revascularized vessels
Feature No CT, No. 3D CT, No. P valuea
Two-vessel FEVAR 8 12
Hypertension 7 10 1
Dyslipidemia 4 8 .6
Chronic pulmonary disease 3 5 1
Smoking 1 1 .6
Coronary artery disease 5 5 .6
Diabetes mellitus 3 4 1
Cerebrovascular disease 1 1 1
Chronic renal insufﬁciencyb 1 2 1
Congestive heart failure 1 2 1
Arrhythmia 1 1 1




Hypertension 32 15 .05
Dyslipidemia 19 8 .4
Chronic pulmonary disease 17 6 .3
Smoking 17 12 .5
Coronary artery disease 13 7 1
Diabetes mellitus 9 4 .7
Cerebrovascular disease 5 3 1
Chronic renal insufﬁciencyb 7 5 .7
Congestive heart failure 5 1 .4
Arrhythmia 4 2 1
End-stage renal disease 0 0 NA
3D CT, Three-dimensional fusion computed tomography; FEVAR, fenes-
trated endovascular aneurysm repair; NA, not applicable; No CT, no
intraoperative computed tomography.
aP values were determined with t-tests, c2, or Fisher exact test when
indicated.
bChronic renal insufﬁciency deﬁned as estimated glomerular ﬁltration rate
< 50 mL/min/1.73 m2 and/or Cr > 1.6.
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Between September 2013 and March 2014, 32
patients underwent FEVAR, and 31 of these wereperformed using 3D fusion CT by a single surgeon
(3D-CT group). One FEVAR was performed in the older
hybrid operating room due to the emergent nature of the
procedure and room availability. In the 12 months prior,
40 patients underwent FEVAR in the non-CT-capable
hybrid operating room, and these were combined with
the patient described previously, making the total no-CT
cohort 41 patients. Demographics, comorbidities, and
aneurysm characteristics of all patients are reported in
Table I. Notably, the mean body mass index of the two
groups is one of the only patient characteristics that was
different and was signiﬁcantly lower in the 3D-CT group
(26 6 4 kg/m2) vs the no-CT group (30 6 6 kg/m2;
P¼ .01). Table II reports demographics and patient charac-
teristics stratiﬁed by the number of vessels revascularized.
Radiation exposure (no CT: 5000 6 280 mGy vs 3D
CT: 2200 6 1300 mGy; P < .0001) and ﬂuoroscopy
time (no CT, 84 6 36 minutes vs 3D CT, 55 6 21 mi-
nutes; P ¼ .0004) were both signiﬁcantly lower in the
3D-CT patients (Fig 2, A and B). In addition, overall
contrast use was lower for the 3D-CT patients (34 6
15 mL) than for no-CT patients (86 6 25 mL; P <
.0001). The difference remained signiﬁcant when divided
into two-vessel (no CT [n ¼ 8]: 69 6 16 vs 3D CT
[n ¼ 12]: 26 6 8; P ¼ .0002) and three-vessel and four-
vessel (no CT [n ¼ 33]: 90 6 25 vs 3D CT [n ¼ 19]:
39 6 17; P < .0001) fenestration groups (Fig 2, C).
Notably, the procedure times were less in the 3D-CT
groups, with a much larger effect in the three-vessel and
four-vessel patients (Fig 2, D). The estimated blood loss
was signiﬁcantly lower estimated in the 3D-CT group
(200 6 180 mL) than in the no-CT group (390 6
380 mL; P < .0001).
Outcomes. Several features of the perioperative details
that may have affected postoperative outcomes are
reported in Table III. Notably, no difference existed in
aneurysm size, extent, urgency, or adjunct use. The 30-day
Fig 2. This ﬁgure demonstrates the reduction in (A) radiation exposure, (B) ﬂuoroscopy time, (C) contrast usage, and
(D) overall procedural time with use of three-dimensional fusion computed tomography (3D CT) technology in
fenestrated endovascular aneurysm repair (FEVAR).
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(n ¼ 2) and 3% (n ¼ 1; P ¼ 1), respectively. A trend toward
a decreased length of stay for the 3D-CT patients (P ¼ .07)
was also observed. Although no signiﬁcant differences in
the rate of postoperative complications was noted between
the no-CT and 3D-CT groups, no spinal cord ischemia
events were observed in the 3D-CT group (P ¼ .06).
Finally, the rates of endoleak and description of the
reinterventions are catalogued in Table IV (any reinterven-
tion, 12% for no CT [n ¼ 5] vs 13% for 3D CT [n ¼ 4];
P ¼ 1). Fenestration patency (all vessels patent in each
group, 34 in no CT vs 27 in 3D CT; P ¼ 1) during
follow-up did not differ between the two groups. In addi-
tion, no signiﬁcant differences were seen with respect to
the eGFR change during follow-up (median [interquartile
range] D eGFR from preoperative to most recent follow-
up: no CT, 0 [5 to 0] vs 3D CT, 0 [4 to 1.5]; P ¼ .6).
DISCUSSION
This study demonstrates that intraoperative 3D fusion
CT signiﬁcantly reduces radiation exposure, contrast use,
and overall procedural time in FEVAR. Although this studywas not powered or designed to detect the effects of this
technology on perioperative outcomes, important metrics,
including blood loss and length of stay, appeared to be
favorably affected. These ﬁndings highlight the potential
physiologic beneﬁts of implementing innovative imaging
techniques in advanced endovascular procedures. In addi-
tion, although we were not able to reliably calculate the
radiation dosage to the provider who performed these pro-
cedures, one may reasonably assume that the substantial
reduction in radiation exposure to the patient also trans-
lated to decreased exposure to all health care providers
participating in these repairs.
A number of factors led to a reduction in radiation
exposure and ﬂuoroscopy time in this study. Most impor-
tantly, the intraoperative CT and vessel origin overlay facil-
itate graft deployment and catheterization of the branch
vessels, thereby decreasing ﬂuoroscopy time. Additional
elements that may have contributed to the observed
decrease in radiation dose and ﬂuoroscopy over time
include subtle technical aspects regarding the vessel-
marking method. Fig 1 demonstrates the markings placed
on the vessel origins, which are traced around the oriﬁce
Table III. Operative details and postoperative outcomes of all fenestrated endovascular repair (FEVAR) patients
Featurea No CT (n ¼ 41) 3D CT (n ¼ 31) P valueb
Aneurysm diameter, mm 67 6 13 65 6 14 .3
Suprarenal/TAAA extent 26 (65) 21 (72) .7
Elective 30 (73) 26 (84)
Urgent/emergency indication 11 (27) 5 (16) .5
Intraoperative adjunct 9 (22) 5 (16) .8
Estimated blood loss, mL 390 6 380 200 6 180 <.0001
Thirty-day mortality 2 (5) 1 (3) 1
Length of stay, days 5 (4-11) 5 (3-8) .07
Complication
Cardiac 5 (12) 3 (10) 1
Pulmonary 5 (12) 1 (3) .2
Renal 6 (15) 1 (3) .2
Bleeding 3 (7) 1 (3) .6
Gastrointestinal 3 (7) 1 (3) .6
Stroke 1 (2) 0 1
Spinal cord ischemia 5 (12) 0 .06
3D CT, Three-dimensional fusion computed tomography; No CT, no intraoperative computed tomography; TAAA, thoracoabdominal aortic aneurysm.
aContinuous data are expressed as mean 6 standard deviation or median (interquartile range) and categoric data as number (%).
bP values were determined with t-tests, c2, or Fisher exact test when indicated.
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wall, producing a circle on the live ﬂuoroscopy overlay.
This circle facilitates precise ﬂuoroscopy usage by allowing
the provider to position the C-arm such that a perpendic-
ular view of the vessel will be seen immediately upon initi-
ation of live ﬂuoroscopy. This decreases the overall
ﬂuoroscopy time and thus decreases the radiation exposure.
Further, although lateral ﬂuoroscopy is typically
required for successful celiac/superior mesenteric artery
catheterization and stenting, the C-arm can be positioned
such that the desired ﬁeld of view and vessel orientation
are ensured before ﬂuoroscopy is initiated. Also, the fenes-
trated device markers can be aligned with the vessel origin
in the anterior-posterior C-arm position, or in slight obliq-
uity, rather than the full lateral position. Eliminating the
need for deep oblique and lateral ﬂuoroscopy in this
manner signiﬁcantly reduces the amount of radiation
required.24 Indeed, reducing the need for prolonged obliq-
uity of the C-arm during FEVAR is tantamount to a reduc-
tion of the overall radiation exposure to the patient and
operating team alike, and in our opinion, this advantage
of 3D fusion CT should be exploited as much as possible.
Lastly, and also very importantly, the need for DSA
imaging is greatly decreased with this new technology
and is reserved primarily for completion imaging. DSA is
used for difﬁcult vessel catheterization at times, but the
frequency is diminished substantially with improved imaging
and 3D overlay on the live ﬂuoroscopic image, despite the
addition of the radiation from the intraoperative CT itself.
We should note that the operator cannot rely entirely
on the intraoperative 3D overlay for device deployment
due to alterations in branch vessel location with the stiff
delivery systems in place. The relationships of the vessels
are frequently altered once the stiff wires and delivery sys-
tem are in the aorta, and the aorta itself may move substan-
tially. The operator thus must be proﬁcient with IVUS
imaging and comfortable with manipulating the overlayto match the IVUS imaging before device deployment.
This concept was recently corroborated by Maurel et al25
in their study demonstrating vessel movement upon intro-
duction of the stiff deployment system during these proce-
dures. Our routine is to perform IVUS imaging with two
stiff Lunderquist wires in place and to adjust the overlay
to match our IVUS image as closely as possible before de-
vice delivery.
With increasing awareness of the possible detrimental
health effects of radiation exposure to patients and health
care providers, investigators and the developers of imaging
products have sought to decrease the radiation required for
these procedures.7,13 Some have suggested that maximum
doses of radiation should be used as benchmarks for hospi-
tal quality and have shown that education and protocol
changes can have a drastic effect on radiation exposure to
patient and health care providers.26,27
To that end, providing advanced imaging technologies
to supplement increasing use of ﬂuoroscopy-based proce-
dures is important, and all of the advanced imaging com-
panies have newer systems with their own respective
proprietary technology to reduce radiation exposure. How-
ever, the importance of adhering to ALARA (as low as [is]
reasonably achievable) principles is equally if not more
important. This includes such things as decreasing the
time on the ﬂuoroscopy pedal, reducing frame rates,
increasing the distance between the provider and the radi-
ation source (especially important during DSA imaging),
diligent use of collimation, avoidance of obliquity unless
necessary, and the proper use of protective shielding during
the procedure. These techniques can also dramatically
reduce radiation exposure to patient and health care pro-
viders, perhaps as much as any other intervention.13,28
In addition, FEVAR has a known association with
renal dysfunction and has been reported to have an asso-
ciated >30% decrement in renal function in 25% to 33%
of patients after the procedure.15,16 This is likely a
Table IV. Comparison of endoleak rates and description of reintervention after fenestrated endovascular aneurysm repair
(FEVAR) with and without intraoperative three-dimensional (3D) fusion computed tomography (CT)
Endoleak typea No CT (n ¼ 32), No. (%) 3D CT (n ¼ 25), No. (%) P valueb
No endoleak 27 (84) 19 (76)
Type Ia/b 0 (0) 0 (0)
Type II 3 (9) 4 (16)
Type III 2 (6) 1 (4)
Type IV 0 (0) 0 (0)
Indeterminate 0 (0) 1 (4) .4
Description of reinterventions
No intraoperative CT patients (n ¼ 5)
d Patient 1: Right renal stent extension/relining for stenosis at 11.5 months
d Patient 2: Jejunal arcade pseudoaneurysm embolization at 1.9 months
d Patient 3: Attempted (failed) left renal bridging stent graft for type III endoleak at 0.6 months
d Patient 4: Left renal stent graft and SMA/ IMA embolization for type III and type II endoleak at 3.4 months
d Patient 5: Celiac and SMA stent grafts for type III endoleak at 1.3 months
Intraoperative 3D fusion CT patients (n ¼ 4)
d Patient 1: SMA stent for “shuttering” of native SMA by scallop at 0.7 months
d Patient 2: Mesenteric embolization for left colon hemorrhage at 1.3 months
d Patient 3: Celiac stent graft for type III endoleak at 1.3 months
d Patient 4: Left renal artery branch vessel embolization and hematoma evacuation at 0.1 months
3D CT, Three-dimensional fusion computed tomography; No CT, no intraoperative computed tomography; IMA, inferior mesenteric artery; SMA, superior
mesenteric artery.
aData are based on patients with available contrasted postoperative CT scans.
bThe P value was determined with the Fisher exact test.
JOURNAL OF VASCULAR SURGERY
Volume 61, Number 2 McNally et al 315multifactorial phenomenon related not only to the pa-
tient’s underlying medical comorbidities but also to the
performance of the operation (atheroemboli and contrast
nephropathy), alterations in branch vessel ﬂow due to
conﬁguration changes induced by the stents, and to the
postoperative contrast-based imaging that is often neces-
sary. All of these factors can be mitigated, and we believe
that the initial insult related to the performance of the
procedure is an excellent starting point for implementa-
tion of renal-protection strategies.
Here we demonstrate that the contrast dose can be
reduced by as much as 60% by using advanced imaging
techniques and conservative dye use. Of note, we have
had a longstanding policy of minimal contrast usage with
FEVAR, and in addition to the imaging improvements,
we typically use one-third strength Visipaque 320 for
hand injection images (both DSA and live ﬂuoroscopy)
and one-half strength for completion aortography. The
ability to use these decreased concentrations is certainly
facilitated by high-quality imaging in both of our hybrid
operating rooms.
The limitations of this analysis include that this is a
single-surgeon, single-institution experience, which inher-
ently introduces bias into the analysis and may not be appli-
cable to all practices. In addition, the effect of the learning
curve on the analysis cannot be fully determined, and there
were certainly ongoing improvements in technical efﬁ-
ciency during the course of the study period. Despite this
issue, there were no signiﬁcant differences in contrast,
radiation, and dye exposure in the initial 68 patients
excluded from the analysis compared with the no-CTcontrol group (data not shown). The lack of staff exposure
data is an unfortunate weakness, but inconsistencies in ra-
diation badge usage were such that we felt that a valid anal-
ysis would not be possible.
Further, owing to the variability in the complexity of
these procedures with respect to access issues, adjunctive
procedures, and the variability in visceral anatomy and
occlusive disease, we cannot account for the effect of
procedural difﬁculty and the effect on radiation exposure
and procedure time. We concluded that an analysis based
on revascularized vessels would allow the fairest analysis
in terms of difﬁculty level, and our data suggest that there
were no signiﬁcant differences in the groups before and
after the initiation of 3D fusion CT with regard to aneu-
rysm extent or adjunct usage.
Finally, the average body mass index of our 3D-CT
patients was lower than the no-CT group, which would
certainly bias the total radiation exposure to be lower in
the 3D-CT group; however, the ﬂuoroscopy time corrob-
orates the 3D-CT radiation dose data, mitigating this
weakness.CONCLUSIONS
FEVAR is an evolving technology that offers a reduced
physiologic effect of complex aortic repair compared with
standard open repair; however, the elevated procedural
complexity leads to increased radiation and dye exposure
risk. The results of our study demonstrate that use of intra-
operative 3D fusion CT imaging during FEVAR decreases
radiation exposure, procedure time, and contrast usage.
JOURNAL OF VASCULAR SURGERY
316 McNally et al February 2015This technology has promising potential to improve the
safety and overall outcomes of these procedures.
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